Xellera Therapeutics is a trusted CDMO committed to driving innovation in Cell and Gene Therapies (CGT) and Advanced Therapy Products (ATP). By delivering GMP-compliant manufacturing solutions, the company empowers researchers and developers to efficiently move from discovery to commercialization, ensuring safe, high-quality, and transformative therapies reach patients globally.